FDA Inspection 1092077 — Children's National Medical Center IRB

Children's National Medical Center IRB — FEI 1177747

The FDA completed an inspection of Children's National Medical Center IRB on June 6, 2019 in Washington, DC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 6, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Washington, DC (United States)

Additional Details

IRB

Citations

IDCFRDescription
729021 CFR 56.108(c)Members present for review
733421 CFR 56.115(a)(5)List of members
734221 CFR 56.108(b)(2)Prompt reporting of noncompliance